Advertisement
Advertisement

RENB

RENB logo

Renovaro Inc. Common Stock

0.837
USD
+0.01
+1.47%
Feb 24, 15:58 UTC -5
Closed
exchange

Pre-Market

0.837

+0.01
+1.47%

Renovaro Inc. Common Stock Profile

About

Renovaro Inc. includes RenovaroCube and Renovaro Biosciences. Renovaro Biosciences is an advanced cell-gene-immunotherapy company. Its lead candidate product is a therapeutic vaccine targeting cancers which are difficult to treat including pancreatic and potentially HNC, triple-negative breast cancer, and advanced liver cancer. Renovaro Inc., formerly known as Renovaro Biosciences Inc., is based in LOS ANGELES.

Info & Links

CEO

Mark Dybul

Headquarters

2080 Century Park East, Suite 906
Los Angeles, CA 90067, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.renovarobio.com

Auditor

Sadler, Gibb & Associates, LLC

Share holders

197

Employees

25

Renovaro Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

132.85M

Enterprise Value

137.66M

Enterprise Value/EBITDA(ttm)

-5.71

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.64

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-61.84%

Return on Invested Capital(ttm)

-109.83%

Return on Assets(ttm)

-48.07%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-24.13M

Net Income Available to Common(ttm)

-126.19M

Diluted EPS(ttm)

-0.93

Share Statistics

Beta (5Y Monthly)

0.63

52-Week Change

-58.56%

S&P 500 52-Week Change

18.02%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

158.72M

Dividend Yield

0.00%

Float4

124.24M

% Held by Insiders

21.72%

% Held by Institutions

71.41%

Balance Sheet

Total Cash(mrq)

311.80K

Total Cash Per Share(mrq)

0.00

Total Debt(mrq)

5.13M

Total Debt/Equity(mrq)

6.25%

Current Ratio(mrq)

0.06%

Quick Ratio(mrq)

0.08%

Book Value Per Share(mrq)

0.51

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.03

Free Cash Flow(ytd)

-4.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement